Company: IPST
Filing Date: 2025-06-04
Form Type: POS AM
Source: 0001641172-25-013501
Chunk: 241

Company: Heritage Distilling Holding Company, Inc.
Filing Date: 2025-06-04
Form: POS AM
Chunk 241
---
 to increase the Company’s authorized capital stock from 10,000,000              
 shares to 70,000,000 shares, including 69,500,000 shares of common stock and 500,000 shares       
 of Founders Common Stock. The increase in authorized shares included provision for the additional 
 shares to be issued with the Company’s anticipated IPO, including those discussed in              
 the following paragraphs, and other future equity activities not yet known.                       |
| ● | filing                                                                                            
 a third amendment to the Company’s amended and restated certificate of incorporation              
 on May 14, 2024, to further increase the Company’s authorized capital stock to 75,000,000         
 shares, including 5,000,000 shares of preferred stock.                                            |

| 145 |

Heritage Distilling Holding Company, Inc.

Notes to Condensed Consolidated Financial Statements

(unaudited)

NOTE 7 — STOCKHOLDERS’ EQUITY / (DEFICIT) (cont.)

ELOC Agreement— On January 23, 2025, the Company entered into an agreement for an equity line of credit purchase agreement (the “ELOC Purchase Agreement”) with an investor (the “ELOC Investor”). Pursuant to the ELOC Purchase Agreement, upon the effectiveness of a related Registration Statement (the “ELOC Registration Statement”) (which was subsequently filed on January 24, 2025) the Company and the investor entered into an equity line of credit purchase agreement whereby the Company will have the right from time to time (at the Company’s option) to direct the Investor to purchase up to $ 15,000,000of the Company’s common stock (subject to certain limitations and conditions. (the “ELOC Purchase Agreement”, or the “Facility”). The amount of sales of common stock to the investor under the ELOC Purchase Agreement (the “ELOC Shares”), and the timing of any sales, will be determined by the Company from time to time in its sole discretion and will depend on a variety of factors, including, among others, market conditions, the trading price of the Company’s shares and determinations by the Company regarding the use of proceeds from any sale of such ELOC Shares. The net proceeds from any sales under the Facility will depend on the frequency with, and prices at, which the ELOC Shares are sold to the Investor.

Under the terms of the ELOC Purchase Agreement, within five (5) business days of the close of execution of the documents for this offering the Company will